Hirsutism and hyperandrogenism
- Approach to a problem
Extra coarse hair in a male pattern is usually PCOS, but now and then it is a tumour. The speed of onset tells you which to fear.
See it in 3D: Ovaries
What it is
Hirsutism is coarse, pigmented terminal hair in a male pattern (upper lip, chin, chest, linea alba, back, thighs) in a woman, from androgen excess or from hair follicles oversensitive to normal androgens. It is graded with the modified Ferriman–Gallwey score; the cut-off varies by ethnic group. Polycystic ovary syndrome causes most cases, followed by idiopathic hirsutism and non-classic congenital adrenal hyperplasia; androgen-secreting ovarian or adrenal tumours, Cushing syndrome, hyperprolactinaemia, thyroid disease and drugs are rarer. Hirsutism differs from hypertrichosis, a diffuse growth of fine hair that is not androgen-driven.
Red flags
- Rapid onset over months, or onset after the mid-20s or after menopause.
- Virilisation: clitoromegaly, deepening voice, temporal balding, increased muscle mass, breast atrophy.
- A very high total testosterone (markedly above the female range) or a very high DHEA-S: ovarian or adrenal tumour.
- Cushingoid features: purple striae, proximal weakness, easy bruising, hypertension.
- A pelvic or abdominal mass.
Step-by-step approach
- Score the hair (modified Ferriman–Gallwey) and separate hirsutism from hypertrichosis and from simple familial or ethnic variation.
- Ask timing, speed, menstrual pattern, acne, weight change, drugs (anabolic steroids, danazol, some antiepileptics) and family history.
- Look for virilisation, acanthosis nigricans, Cushing features, galactorrhoea and a pelvic mass.
- Measure total testosterone (morning, early follicular phase if she cycles), plus pregnancy test, TSH and prolactin.
- Measure 17-hydroxyprogesterone for non-classic congenital adrenal hyperplasia, especially with a family history or high-risk ancestry.
- Very high testosterone or virilisation → pelvic ultrasound or MRI and adrenal imaging; Cushing features → screen for cortisol excess.
- No red flags, irregular cycles or polycystic ovaries → apply the PCOS criteria; normal cycles and androgens → idiopathic hirsutism.
The common and the dangerous causes
| Cause | Onset | Periods | Key test |
|---|---|---|---|
| Polycystic ovary syndrome | Around puberty, slow | Irregular | Mildly raised testosterone; diagnosis by criteria |
| Idiopathic hirsutism | Around puberty, slow | Regular | Normal androgens and ovulation |
| Non-classic congenital adrenal hyperplasia | Puberty or earlier | Regular or irregular | High 17-hydroxyprogesterone |
| Androgen-secreting ovarian or adrenal tumour | Rapid, any age, often later | Often stop | Very high testosterone or DHEA-S; imaging |
| Cushing syndrome | Months | Irregular | Raised cortisol on screening tests |
Keys to the differential
- Mechanism: androgens act on the pilosebaceous unit → vellus hair converts to terminal hair in androgen-sensitive areas; insulin resistance (PCOS) → high insulin → more ovarian androgen and less SHBG → more free testosterone → hirsutism and acne.
- Postmenopausal hirsutism with very high testosterone suggests ovarian hilus cell tumour or hyperthecosis; it is not part of normal ageing beyond a little facial hair.
- Hirsutism has a large psychological burden; ask about distress and treat when she wants it, whatever the score.
Next step / Initial management
- First line for most women: a combined hormonal contraceptive, which suppresses ovarian androgen and raises SHBG; judge the effect after about six months because hair cycles are slow.
- Add an antiandrogen (for example spironolactone or finasteride) if the response is not enough, always with reliable contraception because these drugs can feminise a male fetus.
- Direct hair removal (laser, electrolysis, shaving, waxing) and topical eflornithine work alongside drug treatment.
- Weight loss and metformin help when PCOS with insulin resistance is the cause.
- Refer urgently to endocrinology or gynaecology for rapid onset, virilisation, very high testosterone or DHEA-S, a mass, or suspected Cushing syndrome.
Common traps
- A high hair score means a high testosterone: severity correlates poorly with androgen levels, because follicle sensitivity varies; the speed of onset and virilisation matter more.
- Shaving makes hair grow back thicker: it does not change the follicle; this myth stops women from using a safe method.
- Spironolactone can be prescribed alone to a sexually active woman: it can feminise a male fetus, so it is given with reliable contraception.
- Hirsutism and hypertrichosis are the same: hypertrichosis is diffuse fine hair over the whole body, often from drugs, and is not androgen-driven.
Test yourself
Think of the answer, then tap the question to see it.
A 54-year-old notices new chin hair, a deeper voice and male-pattern balding over six months. Testosterone is very high. What is the next step?
Imaging for an androgen-secreting ovarian or adrenal tumour (pelvic ultrasound or MRI, adrenal CT) and urgent referral; rapid virilisation is a tumour until proven otherwise.
Why must a woman taking spironolactone for hirsutism use reliable contraception?
It blocks androgen receptors and could feminise the genitals of a male fetus.
A 22-year-old has mild hirsutism since puberty, regular ovulatory cycles and normal androgens. What is the likely diagnosis?
Idiopathic hirsutism: increased follicle sensitivity to normal androgen levels.
Why is the effect of treatment judged only after about six months?
Terminal hairs already formed keep growing through their long cycle; the drug only stops new conversion, so improvement shows slowly.
Elsewhere in DurgiPedia
Connections
See it in 3D1
The structures of Durgical's 3D anatomy where it is found.
← All of obstetrics and gynaecology
Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.
Sources: Hirsutism (StatPearls Publishing (NCBI Bookshelf), 2023); Polycystic ovary syndrome (fact sheet) (World Health Organization, 2025).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
